Diabetes and Endocrinology Topic Homepage

Learning Zones

,Adipositas-Lernzentrum

Das Adipositas-Lernzentrum enthält klinische Informationen und Materialien für Gesundheitsexperten, die mit der Behandlung und dem Management von adipösen oder übergewichtigen Patienten befasst sind.

Hier finden Sie ein Wissenszentrum mit Informationen über die Epidemiologie, Pathophysiologie, klinischen Leitlinien, Bewertungs- und Behandlungsoptionen, Präventionsmethoden u. v. m. Andere Bereiche des Lernzentrums beinhalten eine Bibliothek klinischer Medien, neueste Nachrichten und Artikel aus Fachzeitschriften, Informationen über Veranstaltungen, Leitfäden für Patienten sowie die EACCME-akkreditierte CME-Reihe der europäischen Adipositas-Initiative, mit der insgesamt fünf europäische CME-Fortbildungspunkte (ECMECs) erworben werden können.

,Obesity learning hub header ES

El Centro de aprendizaje sobre obesidad contiene información clínica y recursos para profesionales sanitarios que intervienen en el tratamiento y el manejo de pacientes con obesidad o sobrepeso.
Aquí encontrará un Centro de conocimientos con información sobre epidemiología, fisiopatología, directrices clínicas, opciones de tratamiento y evaluación, métodos de prevención y más. Otras secciones del Centro de aprendizaje incluyen una mediateca clínica, noticias y artículos de revistas, información sobre eventos, guías para pacientes y una serie de EMC de la Iniciativa Europea para la Obesidad acreditada por el EACCME que equivale a un total de cinco créditos de EMC europeos.
 

,Obesity LH Portuguese header

​A Plataforma de Aprendizagem sobre Obesidade contém informações clínicas e recursos para profissionais de saúde envolvidos no tratamento e na gestão de doentes obesos ou com excesso de peso.

Encontrará aqui um Centro de Conhecimento com informações sobre epidemiologia, patofisiologia, orientações clínicas, opções de avaliação e tratamento, métodos de prevenção e mais. Outras secções da Plataforma de Aprendizagem incluem uma mediateca clínica, notícias e artigos de publicações especializadas, informações sobre eventos, guias do doente e a série de FMC da Iniciativa Europeia sobre Obesidade, acreditada pelo EACCME, que equivale a um total de cinco créditos europeus de FMC (ECMEC).
,

Qui troverai un Centro didattico con informazioni su epidemiologia, patofisiologia, linee guide cliniche, opzioni terapeutiche e di valutazione, metodi di prevenzione e tanto altro. Le altre sezioni del Centro di apprendimento comprendono una mediateca clinica, notizie e articoli di giornali, informazioni su eventi, guide per i pazienti e la serie CME European Obesity Initiative accreditata dall’EACCME che vale un totale di cinque crediti ECM europei (ECMEC).

,

This educational resource contains a range of content developed for healthcare professionals based in Europe who are involved in the treatment and management of type 2 diabetes mellitus. In this section you will find:

Type 2 Diabetes Mellitus Knowledge Centre: Provides epidemiology statistics, current diagnostic criteria from WHO and ADA, treatment options and a section containing the latest guidelines.

Therapy Focus: Compiles material on emerging insulin/incretin treatment combinations arranged across five informative sections.

‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ CME activity: EACCME-accredited CME activity worth 1 European CME credit (ECMEC).

‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’ CME activityincludes an expert panel discussion video.

,Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial well-being of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC) and should be able to:

  • Describe the psychosocial factors that can affect metabolic control
  • Discuss the rationale and clinical guideline recommendations for psychosocial screening in childhood diabetes
  • Explain the importance of family interactions and dynamics in diabetes management
  • Assess the different behavioural and psychological interventions for optimising diabetes management in children and adolescents
,

El Centro de Experiencia Jardiance▼® (Empagliflozina)* proporciona información sobre el uso de Jardiance.

Jardiance está indicado como medicamento adicional en el tratamiento de la diabetes mellitus tipo 2 en pacientes adultos cuando en combinación con otros medicamentos hipoglucemiantes, junto con la dieta y el ejercicio, no proporcionen un control glucémico adecuado. También está indicado como monoterapia en pacientes adultos en los que el uso de metformina se considere inapropiado debido a una intolerancia.

Los usuarios encontraran cuatro videos de expertos analizando el uso de inhibidores de SGLT2 centrándose en:

  • El paciente adecuado
  • Seguridad
  • Posición recomendada en el escalón terapéutico
  • Mecanismo de acción

*Este contenido es de tipo promocional, esponsorizado por Boehringer Ingelheim y Lilly.

†▼Este medicamento está sujeto a seguimiento adicional, es prioritaria la notificación de sospechas de reacciones adversas a este medicamento

,Obesity Learning Hub

The Obesity Learning Hub contains clinical information and resources for healthcare professionals involved in the treatment and management of obese or overweight patients.

Here you will find a Knowledge Centre with information on epidemiology, pathophysiology, clinical guidelines, assessment and treatment options, prevention methods and more. Other sections within the Learning Hub include a clinical media library, news and journal articles, events information, patient guides and the EACCME-accredited European Obesity Initiative CME series, which is worth five European CME Credits (ECMECs) in total.

,Obesity series

This EACCME-accredited obesity CME series contains three CME modules, which are ideal for healthcare professionals looking to improve their understanding of obesity as a serious medical illness.

Module 1 – Understanding Obesity
Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy.

Module 2 – Considerations for Individualising Pharmacotherapy
Learn about the complexities of obesity, appropriate use of pharmacotherapy for weight management and how to individualise patient care.

Module 3 – Rationale for Lifelong Behaviour Change
Explore the factors affecting maintenance of weight loss, the importance of implementing permanent behaviour changes to prevent weight regain and the components of a successful long-term weight-management strategy.

Upon successful completion of these modules, participants will receive a combined total of five European CME credits (ECMECs).

Latest News

Blog

Diabetes care is a hot topic in medicine since it touches so many primary care settings; from maternity to foot care, Diabetes has multiple other pathologies. When does Diabetes care necessitate the role of a specialist? How can diabetologists ensure they work innovatively and make the patient's healthcare journey as seamless as possible? Dr. Partha Kar dives in, asking how healthcare professionals can make positive change to patients with Diabetes in Britain's NHS.

Medical Videos

Ann T. Sweeney, MD, discusses the efficacy of team-managed insulin initiation compared with a standard approach in patients with type 2 diabetes.
Ann T. Sweeney, MD, discusses the efficacy of team-managed insulin initiation compared with a standard approach in patients with type 2 diabetes.
An Overview of Pancreatic NET and the Available Treatments
An Overview of Pancreatic NET and the Available Treatments
Peter Attia: What if we're wrong about diabetes?
Peter Attia: What if we're wrong about diabetes?
From the Monster's Mouth - A BMJ Investigation into the effects of Type 2 Diabetes Treatments on the Pancreas
From the Monster's Mouth - A BMJ Investigation into the effects of Type 2 Diabetes Treatments on the Pancreas
Type 2 Diabetes - Professor Edwin Gale discusses achievements in diabetes research and the theory around category error.
Type 2 Diabetes - Professor Edwin Gale discusses achievements in diabetes research and the theory around category error.
ADA/EASD Consensus Algorithm for the Treatment of Diabetes Mellitus
ADA/EASD Consensus Algorithm for the Treatment of Diabetes Mellitus
Diabetic Macular Edema
Diabetic Macular Edema
Diuretics, b-blockers, and statins in increasing the risk of type 2 diabetes
Diuretics, b-blockers, and statins in increasing the risk of type 2 diabetes
The Cause of Obesity
The Cause of Obesity

Recent Drug Updates

Medical Journal Abstracts on Diabetes and Endocrinology

Alterations in white matter volume and integrity in obesity and type 2 diabetes.

Wed 27 Jan 2016 -  Alterations in white matter volume and integrity in obesity and type 2 diabetes.

Type 2 diabetes mellitus (T2DM) is characterized by obesity, hyperglycemia and insulin resistance. Both T2DM and obesity are associated with cerebral complications, including an increased risk of ...

Liraglutide and obesity in elderly: efficacy in fat loss and safety in order to prevent sarcopenia. A perspective case series study.

Sat 09 Jan 2016 -  Liraglutide and obesity in elderly: efficacy in fat loss and safety in order to prevent sarcopenia. A perspective case series study.

Background: For the growing numbers of obese elderly with diabetes, the glucagon-like peptide-1 (GLP-1) receptor analogue (liraglutide) appears a safe way to promote and maintain substantial weight ...

Clinical Guidelines

Type 2 diabetes: The management of type 2 diabetes

Dec 2015

This guideline contains recommendations for managing type 2 diabetes in adults, and focuses on..

... patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications. The guideline does not cover diagnosis, secondary diabetes, type 1 diabetes in adults, diabetes in pregnancy and diabetes in children and young people.

Menopause: diagnosis and management

Nov 2015

This guideline covers the diagnosis and management of menopause, including in women who have..

... premature ovarian insufficiency. The guideline aims to improve the consistency of support and information provided to women in menopause.

Who is it for?
- Healthcare professionals who care for women in menopause.
- Women in menopause, and their families and carers.

The guideline includes recommendations on:
- Individualised care
- Diagnosis of perimenopause and menopause
- Information and advice
- Managing short-term menopausal symptoms
- Long-term benefits and risks of hormone replacement therapy
- Diagnosing and managing premature ovarian insufficiency

Online CME

Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin

Healthcare professionals can enhance their understanding of the combination therapies available for treating type 2 diabetes by completing this free activity. ‘Best Practice in Type 2 Diabetes: Update on Incretin...

Considerations for Individualising Pharmacotherapy

Learn about the complexities of obesity, appropriate use of pharmacotherapy for weight management and how to individualise patient care. EACCME accredited.

Understanding Obesity

Learn more about obesity as a serious and complex medical illness including comorbidities and complications, the complex factors that influence its development and the cornerstones of an effective weight-management strategy....

Clinical Trials

Energy Balance in Craniopharyngioma-related Hypothalamic Obesity (ECHO)

-21 days ago

The proposed multicenter study will test the effect of glucagon-like peptide (GLP)-1 agonist exenatide once weekly extended-release (ExQW, Bydureon®) on clinical outcomes and metabolic ...

Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients

7 days ago

The purpose of this study is to determine whether liraglutide a GLP-1 analogue are effective in the treatment of diastolic dysfunction in type 2 diabetes patients analyzed by cardiac MRI. Secondary ...

Back to top